SGC
ZBH icon

Slocum, Gordon & Co’s Zimmer Biomet ZBH Stock Holding History

Slocum, Gordon & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25
Closed -$2.28K – 127
2025
Q2 		$2.28K Hold
25
– – ﹤0.01% 114
2025
Q1 		$2.83K Hold
25
– – ﹤0.01% 123
2024
Q4 		$2.64K Hold
25
– – ﹤0.01% 126
2024
Q3 		$2.7K Hold
25
– – ﹤0.01% 126
2024
Q2 		$2.71K Buy
+25
New +$2.95K ﹤0.01% 133

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Slocum, Gordon & Co's ZBH Position: Q3 2025 in Review

Slocum, Gordon & Co sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 25 shares — an estimated $2.28K sold.

Slocum, Gordon & Co first reported a position in ZBH in Q2 2024 and held it in 5 quarters. The position peaked at $2.83K in Q1 2025. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

  • Slocum, Gordon & Co reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
  • Slocum, Gordon & Co sold 25 Zimmer Biomet shares in Q3 2025, an estimated $2.28K.
  • Slocum, Gordon & Co first reported a position in Zimmer Biomet in Q2 2024 and held it in 5 quarters.
  • Slocum, Gordon & Co's Zimmer Biomet position peaked at $2.83K in Q1 2025.
  • 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Slocum, Gordon & Co's 13F filing for Q3 2025, filed 17 Oct 2025.